Free Trial
Kyle Boucher

Kyle Boucher Analyst Performance

Vice President, Equity Research at TD Cowen

Kyle Boucher is a stock analyst at TD Cowen in the healthcare sector, covering 4 publicly traded companies. Over the past year, Kyle Boucher has issued 10 stock ratings, including buy and hold recommendations. While full access to Kyle Boucher's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Boucher's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 1 Years
Buy Recommendations
25.00% 3 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy25.0%3 ratings
Hold75.0%9 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Kyle Boucher at TD Cowen, the majority (75.0%) have been Hold recommendations, followed by 25.0% Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
4 companies

Kyle Boucher, an analyst at TD Cowen, currently covers 4 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
4 companies
100.0%

Kyle Boucher of TD Cowen specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
LIFE SCIENCES TOOLS & SERVICES
3 companies
75.0%
BIOTECHNOLOGY
1 company
25.0%

Kyle Boucher's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
11/5/2026Boost Price Target$6.18$6.75Hold
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
10/13/2026Boost Price Target$4.09$4.50Hold
Bruker Corporation stock logo
BRKR
Bruker
10/13/2026Boost Price Target$55.06$62.00Hold
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
7/31/2026Lower Price Target$3.11$4.00Hold
Bruker Corporation stock logo
BRKR
Bruker
7/15/2026Reiterated Rating$60.59Hold
Bio-Techne Corp stock logo
TECH
Bio-Techne
6/29/2026Downgrade$70.90$73.00Hold
Bruker Corporation stock logo
BRKR
Bruker
5/7/2026Boost Price Target$43.32$45.00Hold
Myriad Genetics, Inc. stock logo
MYGN
Myriad Genetics
5/6/2026Lower Price Target$4.14$6.00Hold
Bio-Techne Corp stock logo
TECH
Bio-Techne
3/17/2026Reiterated Rating$50.51Buy
Bio-Techne Corp stock logo
TECH
Bio-Techne
2/5/2026Reiterated Rating$68.67$80.00Buy
Standard BioTools Inc. stock logo
LAB
Standard BioTools
11/5/2025Lower Price Target$1.14$1.35Hold
Bio-Techne Corp stock logo
TECH
Bio-Techne
10/14/2025Boost Price Target$59.65$70.00Buy